BioSpace News Archive

Q BioMed, Inc. a commercial-stage biotechnology development company outlines its strategy and value proposition for its stakeholders and shareholders.

Adaptiiv Medical Technologies Inc. (Adaptiiv) is collaborating with HP Inc. (HP) and Varian, a Siemens Healthineers company (Varian), to advance the quality of and access to personalized cancer care for U.S. patients with 3D printed medical devices.

High prevalence of chronic diseases and infections, rising number of surgeries, increasing need for constant blood supply in health centers, and rapid advancements in blood collection devices are some key factors expected to drive global blood collection market revenue growth.

Ocugen, Inc. reported first quarter 2022 financial results along with a general business update.

VYNE Therapeutics Inc. announced that David Domzalski, Chief Executive Officer, and Dr. Iain Stuart, Chief Scientific Officer, will present at LifeSci Partners’ virtual Immunology and Inflammation Symposium, taking place May 10th-11th, 2022.

Biofrontera Inc. (Nasdaq: BFRI), will report financial results for the three months ended March 31, 2022 before the opening of the U.S. financial markets on Friday, May 13, 2022 and will hold a conference call that same day beginning at 11:00 a.m. Eastern time to discuss those results, provide a business update and answer questions.

The industry analysis report is considered a valuable source of information about the global Physical Vapor Deposition (PVD) Medical Devices industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

ViewRay, Inc. announced that the company’s MRIdian MRI-guided radiation therapy system will be featured at the Annual Meeting of the European Society for Radiotherapy and Oncology, with nearly 40 presentations and posters highlighting MRIdian clinical and research experience.

DUBAI, United Arab Emirates, The global Cotinine Screening Devices Market recorded sales worth U.S. $ 429.9 Mn in the year 2021.

Albany NY, United States: Bronchopulmonary dysplasia, a type of chronic lung disorder, affects newborns, mostly premature and infants.